196 related articles for article (PubMed ID: 18673444)
1. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
Pizarro CB; Oliveira MC; Pereira-Lima JF; Leães CG; Kramer CK; Schuch T; Barbosa-Coutinho LM; Ferreira NP
Neuropathology; 2009 Feb; 29(1):40-4. PubMed ID: 18673444
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD-105 antigen.
Gadbail AR; Hande A; Chaudhary M; Nikam A; Gawande M; Patil S; Tekade S; Gondivkar S
J Oral Pathol Med; 2011 Mar; 40(3):263-9. PubMed ID: 20969632
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
9. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
10. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas.
Hou XZ; Liu W; Fan HT; Liu B; Pang B; Xin T; Xu SC; Pang Q
Neuro Oncol; 2010 Aug; 12(8):799-803. PubMed ID: 20200025
[TBL] [Abstract][Full Text] [Related]
12. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
[TBL] [Abstract][Full Text] [Related]
13. Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes.
Rotondo F; Sharma S; Scheithauer BW; Horvath E; Syro LV; Cusimano M; Nassiri F; Yousef GM; Kovacs K
Neoplasma; 2010; 57(6):590-3. PubMed ID: 20845998
[TBL] [Abstract][Full Text] [Related]
14. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density in pituitary adenomas and carcinomas.
Vidal S; Kovacs K; Horvath E; Scheithauer BW; Kuroki T; Lloyd RV
Virchows Arch; 2001 Jun; 438(6):595-602. PubMed ID: 11469692
[TBL] [Abstract][Full Text] [Related]
17. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count.
Romani AA; Borghetti AF; Del Rio P; Sianesi M; Soliani P
J Surg Oncol; 2006 May; 93(6):446-55. PubMed ID: 16615157
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in craniopharyngiomas: Microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin.
Dallago CM; Oliveira MC; Barbosa-Coutinho LM; Ferreira NP
Endocr Pathol; 2005; 16(4):355-62. PubMed ID: 16627922
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
20. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
